EUVIMEDDescoperă EUVIMED
EUVIMED · CrossrefJournal

Blood Cancer Journal

ISSN 2044-5385 · Springer Science and Business Media LLC

Latest articles

  1. Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)

    Douglas W. Sborov, Anuj K. Mahindra, Vera J. Suman, Elisabet Esteve Manasanch, Prashant Kapoor, Tibor Kovacsovics, Cesar Rodriguez, Benjamin Parsons, Jose Eugenio Najera, Lyle Goldman, Destin Carlisle, Yujia Wen, Shira H. Dinner, Ilene A. Galinsky, LeAnne Kennedy, James Omel, Philip McCarthy, Saad Usmani, Paul G. Richardson

    Published: 2026-11-16DOI: 10.1038/s41408-026-01674-w

  2. Implications of TP53 mutations in patients with higher risk myelodysplastic syndromes (MDS) who received hypomethylating agent therapy: an analysis from the VALIDATE database of the International Consortium for MDS

    Tariq Kewan, Jan Philipp Bewersdorf, Luca Lanino, Ondrej Blaha, Jessica M. Stempel, Najla H. Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Geoffrey L. Uy, Samuel Urrutia, Hetty E. Carraway, Pinkal Desai, Elizabeth A. Griffiths, Eytan M. Stein, Andrew M. Brunner, Christine McMahon, Rory M. Shallis, Joshua F. Zeidner, Hayley Hawkins, Michael R. Savona, Namrata Sonia Chandhok, Constantine Logothetis, Aram Bidikian, Ted M. Getz, Gail J. Roboz, Benjamin Rolles, Eunice S. Wang, Amyah C. Harris, Maria L. Amaya, Somedeb Ball, Justin Grenet, Zhuoer Xie, Yazan F. Madanat, Yasmin Abaza, Talha Badar, Torsten Haferlach, Jaroslaw P. Maciejewski, Anoop Enjeti, Kamal Al-Rabi, Khalid Halahleh

    Published: 2026-11-14DOI: 10.1038/s41408-026-01584-x

  3. Impact of residual clonal plasma cell proliferation rate after autologous stem cell transplant on outcomes in multiple myeloma

    Tamer Hellou, Daniel G. Packard, Maximilian J. Steinhardt, Shaji K. Kumar, Angela Dispenzieri, Saurabh Zanwar, Shinichiro Suzuki, Estefania Gauto Mariotti, Dragan Jevremovic, Horatiu Olteanu, Pedro Horna, Gregory Otteson, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Joselle Cook, Nadine Abdallah, Moritz Binder, Rahma Warsame, Taxiarchis V. Kourelis, Ronald S. Go, Yi Lin, Eli Muchtar, S. Vincent Rajkumar, Wilson I. Gonsalves, Morie A. Gertz

    Published: 2026-11-13DOI: 10.1038/s41408-026-01676-8

  4. Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010)

    Melinda SY Tan, Kye Ling Wong, Cinnie Soekojo, Chandramouli Nagarajan, Sarah Burkhill, Xinhua Li, Ho-Jin Shin, Jong Heon Jung, Yeung-Chul Mun, Ho-Young Yhim, Jae Hoon Lee, Ling Cao, Tadao Ishida, Chihiro Shimazaki, Makoto Sasaki, Hiroyuki Takamatsu, Shinsuke Iida, Hirono Iriuchishima, Shuji Ozaki, Karen Tang, Jeffrey Huang, Jerry Teng, Cheng-Shyong Chang, Changki Min, Wenming Chen, Hiroshi Handa, Kihyun Kim, Priti Bahety, Juan Du, Wee Joo Chng

    Published: 2026-11-11DOI: 10.1038/s41408-026-01641-5

  5. Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies

    Ahmed L. Al-Mashhadi, Mikkel R. Simonsen, Elizabeth Smyth, Rose-Marie Amini, Bente Arboe, James R. Cerhan, Iman Chanchiri, Chan Y. Cheah, Jonathan R. Day, Toby A. Eyre, Anne O. Gang, Herve Ghesquieres, Thomas M. Habermann, Eliza Hawkes, Steven Hwang, Ruxandra Irimia, Jennifer B. Jørgensen, Arushi Khurana, Claire Maquet, Matthew Maurer, Lay She Ng, Stephen Opat, Martin B. Pedersen, Christian B. Poulsen, Alexandros Rampotas, Andreea Sima, Karin E. Smedby, Knut B. Smeland, Gita Thanarajasingam, Judith Trotman, Katharine Xing, Simon Østergaard, Diego Villa, Tarec C. El-Galaly

    Published: 2026-11-09DOI: 10.1038/s41408-026-01660-2

  6. Biomarkers of cellular senescence and their association with frailty, clinical outcomes, and survival in multiple myeloma

    Nadine Abdallah, Byron Smith, Thomas A. White, Amanda Heeren, Tanya M. Wildes, Rosalynn Marar, Claire Yee, Anna Bodily, Brian Kotajarvi, Sarah Aug, Francis Buadi, Prashant Kapoor, Angela Dispenzieri, Suzanne Hayman, David Dingli, Wilson Gonsalves, Joselle Cook, Saurabh Zanwar, Moritz Binder, Yi Lin, Taxiarchis Kourelis, Morie A. Gertz, Rahma Warsame, S. Vincent Rajkumar, Jad Sfeir, Nathan K. LeBrasseur, Shaji K. Kumar, Megan M. Weivoda

    Published: 2026-10-30DOI: 10.1038/s41408-026-01652-2

  7. Nivolumab consolidation in patients with double and triple hit high-grade B-cell lymphoma in complete metabolic remission after DA-EPOCH-R

    A. Vera de Jonge, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara P. W. Klerk, Yorick Sandberg, Rozemarijn van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke K. J. Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Bohmer, Laurens Nieuwenhuizen, Wendy B. C. Stevens, Roel van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S. P. Vermaat, Otto Visser, Josée M. Zijlstra, Anne I. J. Arens, Ben Zwezerijnen, Danielle van Assema, Bart de Keizer, Henk Hofwegen, Helma Zanders, Brigitta A. G. Schuthof, Robby E. Kibbelaar, Lianne Koens, Liping Fu, Daphne de Jong, David Kurtz, Marcel Nijland, Marie José Kersten, Martine E. D. Chamuleau

    Published: 2026-10-30DOI: 10.1038/s41408-026-01657-x

  8. Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia

    Mahnoor Fatima, Sudhesh Kumar, Momna Warraich, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek Mangaonkar, Antoine N. Saliba, Mark R. Litzow, William Hogan, Mithun V. Shah, Mrinal M. Patnaik, Animesh Pardanani, Talha Badar, James Foran, Jeanne Palmer, Cecilia Arana Yi, Ayalew Tefferi, Naseema Gangat

    Published: 2026-08-17DOI: 10.1038/s41408-026-01612-w

  9. Hair bulb and oral mucosa DNA for prompt germline testing in hematologic neoplasms

    Ferran Balbastre-Úbeda, Sara Torres-Esquius, Maria Gabarrós-Subirà, Francisco Beas, Jordi Leno-Colorado, Cristina Sanchez-Morales, Tzu Hua Chen-Liang, Susana Urban-Giral, Meritxell Tena-Alegre, Ana María Hurtado, María Jesús Casas-Tio, Ana María Garrido, Pamela Acha, Adoración Blanco, Francesc Solé, Mónica Del Rey, María Díez-Campelo, David Valcárcel, Maria Julia Montoro, Andrés Jerez, Mónica Del Rey

    Published: 2026-08-11DOI: 10.1038/s41408-026-01602-y

  10. Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma

    Alice X. Wang, Tala Shekarkhand, David Nemirovsky, Andriy Derkach, Carlyn R. Tan, Issam S. Hamadeh, Ross S. Firestone, Eric Jurgens, Kevin Miller, Dhwani Patel, Neha Korde, Alexander M. Lesokhin, Sham Mailankody, Hani Hassoun, Hamza Hashmi, Sridevi Rajeeve, Urvi A. Shah, Kylee Maclachlan, Gunjan L. Shah, Michael Scordo, Heather J. Landau, Sergio A. Giralt, Saad Z. Usmani, Malin Hultcrantz

    Published: 2026-08-07DOI: 10.1038/s41408-026-01594-9

Volumes

2026 · 2232025 · 2272024 · 2242023 · 1942022 · 1732021 · 2032020 · 1262019 · 1022018 · 1282017 · 1422016 · 1352015 · 1102014 · 992013 · 702012 · 502011 · 48

Cunoștințe potrivite muncii dumneavoastră.

De la începutul gratuit și cercetarea bibliografică personală până la Research Suite complet.

Vezi tarifele →

Sunt incluse toate textele integrale ale editorilor?

Nu. Referințele bibliografice, rezumatele și textele integrale sunt conținuturi diferite. Disponibilitatea unui text integral depinde de sursă, de Open Access și de licențele pe care le aveți deja. Un abonament EUVIMED nu înlocuiește drepturile suplimentare ale editorilor.